FlexNP's Avatar

FlexNP

@rnflex

Jack of all trades nurse practitioner, trail runner photographer, coonhound rescuer, lover of glucagon agonism in the liver, kidney and pancreas, fascinated by obesity medicine, retatrutide fan boy

2,696
Followers
466
Following
5,046
Posts
19.06.2023
Joined
Posts Following

Latest posts by FlexNP @rnflex

The drugs are part of the toolbox. Yes avoid high calorie foods. Yes move your body. But also for a lot of my patients the drugs *allow* them to do those things.

07.03.2026 14:48 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

The biggest issue is we've created an entire world with less physical labor, more convenient *everything* more high calorie *everything* you can live a comfortable sedentary life because that's the world society built.

Not an excuse but reality.

07.03.2026 14:48 ๐Ÿ‘ 2 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

And I'll add you get to navigate some really weird contradictory information while still trying to be understanding.

One patient took every vaccine we offer but HPV. Calling that one the "vaccine for wh*res"

And you just have to maintain the poker face professionalism

07.03.2026 12:22 ๐Ÿ‘ 15 ๐Ÿ” 1 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0
Post image Post image

The one of the next frontiers for GLP1 meds is neuroscience/addiction disorders. This recently published study looking at various substance use disorders and older GLP1 medications shows a modest benefit across the board

www.bmj.com/content/392/...

06.03.2026 12:42 ๐Ÿ‘ 3 ๐Ÿ” 2 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

Oof why the hell....79-80 is where I have the "what meds do you not wanna take anymore" talk because that's the point of rapidly diminished returns!

06.03.2026 18:36 ๐Ÿ‘ 0 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0

Oof. Yeah that's an issue. Overnight to charge the plug in is usually a $1-1.25 per 45 miles with our overnight rates so that math works well in our favor.

My bigger issue is all the public charging stations are stupid expensive

06.03.2026 17:03 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

As I said earlier, glad to have a plug in hybrid that gets ~45 miles to a charge and only needs gas about once a month with our driving habits

06.03.2026 16:19 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

Boy am I glad our one car is a plug-in hybrid and basically needs gas about once a month or less, especially in warmer weather months.

06.03.2026 14:14 ๐Ÿ‘ 5 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0

This is such a truth bomb. Even tho I do PCP work the amount of patients who stop meds because they ballooned 40 pounds on an atypical antipsychotic is innumerable.

06.03.2026 13:10 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

A dual GIP/GLP1 would directly counteract those effects. And if it happens to have a benefit of mood stabilization that would be incredible. These drugs continue to do amazing things and I can't wait to see what the next couple years brings.

06.03.2026 12:42 ๐Ÿ‘ 2 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0
Post image

It's called Brenipatide and it now has 8 trials running mostly for SUD but also for adjunctive therapy for depression, bipolar and schizophrenia. Psych meds, especially for BPD and schizo are well known to increase lipids, cause weight gain and insulin resistance.

06.03.2026 12:42 ๐Ÿ‘ 2 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 1
Post image Post image

It even shows, importantly a decrease in mortality (tho the CI is broad) regardless about a 20% reduction in SUD is nothing to sneeze at when you consider our current treatments. I believe this also explains why Eli Lilly has went hard into SUD and mental health with a new GLP1/GIP dual agonist

06.03.2026 12:42 ๐Ÿ‘ 0 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0
Post image Post image

The one of the next frontiers for GLP1 meds is neuroscience/addiction disorders. This recently published study looking at various substance use disorders and older GLP1 medications shows a modest benefit across the board

www.bmj.com/content/392/...

06.03.2026 12:42 ๐Ÿ‘ 3 ๐Ÿ” 2 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

Yup. Definitely have those days on occasion even after 2.5 years I still have days where I'll get post shot fatigue or some extra intense appetite suppression or satiety. But 95% of the time it's just nice to not think about food all the time and feel so much healthier.

Hope the same for you

06.03.2026 02:27 ๐Ÿ‘ 4 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0
Post image

!!!!!!! ๐Ÿ‘€๐Ÿ‘€

Trial finished on February 20th...so we should have initial topline phase 3 data for retatrutide and diabetic patients over a 40 week period in late March!!!! Ahhhhhhh!!!!

05.03.2026 15:45 ๐Ÿ‘ 6 ๐Ÿ” 1 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0
Post image

BIC tolerability confirmed. But the weight loss is....consistent?

05.03.2026 22:49 ๐Ÿ‘ 2 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0
Post image

Yes ma'am!

05.03.2026 21:23 ๐Ÿ‘ 0 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

The Kwikpen you can dial a dose by counting clicks ๐Ÿ˜‰

05.03.2026 21:13 ๐Ÿ‘ 0 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

CEO be dumb! I mean probably best in class tolerability it sounds like. But the weight loss is ๐Ÿ™ˆ

05.03.2026 20:52 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0

I'm all for more weight loss options, especially tolerable ones but this one ain't great!

Once again I suspect calcitonin is holding it back.

Also I wouldn't be so harsh if the CEO hadn't said this would be best in class results. Ahhh nope. Not even close.

05.03.2026 20:49 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

Another DACRA. Another subpar weight loss result. Just say no to DACRA for weight loss. Petrelintide is a Amylin 3R-Calcitonin agonist. Tolerability was great. Similar to placebo.

Weight loss was only 9% and only for the highest dose. No report on other doses.

05.03.2026 20:49 ๐Ÿ‘ 0 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0
Post image

!!!!!!! ๐Ÿ‘€๐Ÿ‘€

Trial finished on February 20th...so we should have initial topline phase 3 data for retatrutide and diabetic patients over a 40 week period in late March!!!! Ahhhhhhh!!!!

05.03.2026 15:45 ๐Ÿ‘ 6 ๐Ÿ” 1 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0

That is a true galaxy brain take. Make the highly flammable tankers pass through an even MORE NARROW choke point.

*After you literally blast a path through mountains that are >4000 feet high

05.03.2026 15:20 ๐Ÿ‘ 3 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0

Their other expenses go down. Less on groceries especially. They can easily recoup that cost from cost savings on food. Also many can stop other meds like BP meds as their weight comes down.

Ultimately this is a massive win for long term access. Let the price wars continue!

05.03.2026 14:33 ๐Ÿ‘ 3 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0

For example an employer could add this as a rider that patients buy to defray the cost. Employer might pay $300 of that 449, leaving the patient to pay 149/month for Zepbound. Expensive yes BUT a lot of my patients are willing to pay that amount monthly because....

05.03.2026 14:33 ๐Ÿ‘ 3 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

especially because the PBMs have not been passing through 100% of the rebates, they pocket most of that money for themselves!

Employers would then determine how much they would shoulder and how much to pass on to their employees if they want to add Zepbound to their list of covered drugs

05.03.2026 14:33 ๐Ÿ‘ 2 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

What does that mean in English?

The $449 cost (plus whatever fees come from the program administrator some of which have lower overheads than others IS LIKELY lower than the net prices plans/employers are receiving via insurance/PBMs after "rebates" aka kickbacks to the PBM from Lilly

05.03.2026 14:33 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

Huge announcement by Eli Lilly this morning that undercuts PBMs and their competitor Novo

"Zepboundยฎ (tirzepatide) KwikPenยฎ for single-patient use available from Lilly at $449 across all doses through the Lilly Employer Connect platform, with reduced cost-share pricing available to employees"

05.03.2026 14:33 ๐Ÿ‘ 4 ๐Ÿ” 0 ๐Ÿ’ฌ 3 ๐Ÿ“Œ 0

Gotta say the 2 trials Lilly is running with tirzepatide for T1D have me very excited for you and millions of other T1D patients. Better glycemic control, less insulin, better renal outcomes. Would be a huge boon for T1D if approved in a couple years

05.03.2026 10:35 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0

The irony is RFK absolutely has to be using melanotan to have that level of tan skin.

04.03.2026 22:29 ๐Ÿ‘ 2 ๐Ÿ” 0 ๐Ÿ’ฌ 0 ๐Ÿ“Œ 0